Expression of SPCS2 in glioma - The Human Protein Atlas

GLIOBLASTOMA MULTIFORME (TCGA) - Interactive survival scatter plotⁱ

The Survival Scatter plot shows the clinical status (i.e. dead or alive) for all individuals in the patient cohort, based on the same data that underlies the corresponding Kaplan-Meier plots. Patients that are alive at last time for follow-up are shown in blue and patients who have died during the study are shown in red.

The x-axis shows the expression levels (FPKM) of the investigated gene in the tumor tissue at the time of diagnosis. The y-axis shows the follow-up time after diagnosis (years). Both axes are complimented with kernel density curves demonstrating the data density over the axes. The top density plot shows the expression levels (FPKM) distribution among dead (red) and alive patients (blue). The right density plot shows the data density of the survived years of dead patients with high and low expression levels respectively, stratified using the cutoff indicated by the vertical dashed line through the Survival Scatter plot. This cutoff is automatically defined based on the FPKM cutoff that minimizes the p-score. The cutoff can be changed by dragging the vertical line or by entering a cutoff value in the square labeled "Current cut-off".

Under the Survival Scatter plot the p-score landscape (black curve; left axis) is shown together with dead median separation (red curve; right axis). Dead median separation is the difference in median mRNA expression between patients who have died with high and low expression, respectively. It is calculated as follows: median FPKM expression of dead patients with high expression - median FPKM expression of dead patients with low expression. This is intended to aid the user in visually exploring custom cutoffs and the associated p-scores and dead median separation.

Individual patient data is displayed and can be filtered by clicking on one or more of the category buttons on the top of the page. Categories describing expression level and patient information include: high, low, alive, dead, female, male and tumor stages. The scale of the x-axis can be toggled between linear and log-scale by clicking on the "x log" button. Mouse-over function shows TCGA ID, patient information and mRNA expression (FPKM) for each patient.

& Survival analysisⁱ

SPCS2 is not prognostic in Glioblastoma Multiforme (TCGA)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 225.49

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

218.5

Number of samples

141

Samples

Sample	Description	pTPM
TCGA-28-5220-01A	67 years, male, white, stage:'--, dead, 388 days	390.7
TCGA-12-0821-01A	62 years, male, white, stage:'--, dead, 323 days	343.8
TCGA-28-5204-01A	72 years, male, white, stage:'--, dead, 454 days	322.5
TCGA-26-5139-01A	65 years, female, white, stage:'--, alive, 48 days	311.7
TCGA-27-2528-01A	62 years, male, white, stage:'--, dead, 480 days	296.6
TCGA-28-5209-01A	66 years, female, white, stage:'--, alive, 442 days	295.5
TCGA-27-2523-01A	63 years, male, white, stage:'--, dead, 489 days	292.0
TCGA-28-5208-01A	52 years, male, white, stage:'--, dead, 544 days	285.9
TCGA-06-5417-01A	45 years, female, white, stage:'--, alive, 155 days	285.1
TCGA-06-2565-01A	59 years, male, asian, stage:'--, dead, 506 days	281.5
TCGA-28-2514-01A	45 years, male, asian, stage:'--, alive, 160 days	280.0
TCGA-76-4925-01A	76 years, male, white, stage:'--, dead, 146 days	276.2
TCGA-06-5413-01A	67 years, male, white, stage:'--, alive, 268 days	276.2
TCGA-06-2564-01A	50 years, male, white, stage:'--, alive, 181 days	274.6
TCGA-14-0787-01A	69 years, male, asian, stage:'--, dead, 68 days	273.3
TCGA-06-0156-01A	57 years, male, white, stage:'--, dead, 178 days	269.6
TCGA-06-5408-01A	54 years, female, white, stage:'--, dead, 357 days	269.1
TCGA-14-1034-01A	60 years, female, stage:'--, dead, 485 days	267.8
TCGA-02-2483-01A	43 years, male, asian, stage:'--, alive, 466 days	267.5
TCGA-06-0210-01A	72 years, female, white, stage:'--, dead, 225 days	267.0
TCGA-28-5215-01A	62 years, female, white, stage:'--, dead, 335 days	266.1
TCGA-06-0878-01A	74 years, male, white, stage:'--, alive, 218 days	264.0
TCGA-06-2559-01A	83 years, male, white, stage:'--, dead, 150 days	263.1
TCGA-06-5414-01A	61 years, male, white, stage:'--, alive, 273 days	261.3
TCGA-14-2554-01A	52 years, female, white, stage:'--, dead, 532 days	261.0
TCGA-12-5299-01A	56 years, female, white, stage:'--, dead, 98 days	260.0
TCGA-06-5858-01A	45 years, female, white, stage:'--, alive, 187 days	258.3
TCGA-27-2519-01A	48 years, male, white, stage:'--, dead, 550 days	257.8
TCGA-06-0211-01A	47 years, male, white, stage:'--, dead, 360 days	256.6
TCGA-06-0745-01A	59 years, male, white, stage:'--, dead, 239 days	254.5
TCGA-28-5216-01A	52 years, male, white, stage:'--, alive, 415 days	252.3
TCGA-06-5859-01A	63 years, male, white, stage:'--, alive, 139 days	251.0
TCGA-06-0157-01A	63 years, female, white, stage:'--, dead, 97 days	250.6
TCGA-27-2526-01A	79 years, female, white, stage:'--, dead, 87 days	249.3
TCGA-32-1970-01A	59 years, male, white, stage:'--, dead, 468 days	249.0
TCGA-02-2485-01A	53 years, male, black or african american, stage:'--, alive, 470 days	247.7
TCGA-14-1829-01A	57 years, male, black or african american, stage:'--, alive, 218 days	247.3
TCGA-15-1444-01A	21 years, male, white, stage:'--, dead, 1537 days	246.3
TCGA-76-4931-01A	70 years, female, white, stage:'--, dead, 279 days	245.7
TCGA-06-0129-01A	30 years, male, asian, stage:'--, dead, 1024 days	244.8
TCGA-12-3653-01A	34 years, female, white, stage:'--, dead, 442 days	244.7
TCGA-41-5651-01A	59 years, female, black or african american, stage:'--, dead, 460 days	244.0
TCGA-08-0386-01A	74 years, male, white, stage:'--, dead, 548 days	240.5
TCGA-06-0174-01A	54 years, male, white, stage:'--, dead, 98 days	240.5
TCGA-06-2561-01A	53 years, female, white, stage:'--, dead, 537 days	238.2
TCGA-15-0742-01A	65 years, male, white, stage:'--, dead, 419 days	238.1
TCGA-06-0187-01A	69 years, male, white, stage:'--, dead, 828 days	237.5
TCGA-12-5295-01A	60 years, female, white, stage:'--, dead, 454 days	237.3
TCGA-06-2562-01A	81 years, male, white, stage:'--, dead, 382 days	235.6
TCGA-06-5418-01A	75 years, female, white, stage:'--, dead, 83 days	235.3
TCGA-14-0789-01A	54 years, male, white, stage:'--, dead, 342 days	235.3
TCGA-06-5416-01A	23 years, female, white, stage:'--, alive, 204 days	235.2
TCGA-27-1834-01A	56 years, male, white, stage:'--, dead, 1233 days	235.0
TCGA-14-1825-01A	70 years, male, white, stage:'--, dead, 232 days	234.2
TCGA-06-0168-01A	59 years, female, white, stage:'--, dead, 598 days	233.8
TCGA-06-2570-01A	21 years, female, white, stage:'--, alive, 958 days	233.1
TCGA-32-2638-01A	67 years, male, white, stage:'--, dead, 766 days	231.4
TCGA-02-0047-01A	78 years, male, white, stage:'--, dead, 448 days	229.2
TCGA-32-2634-01A	82 years, male, white, stage:'--, alive, 693 days	228.9
TCGA-12-3652-01A	60 years, male, white, stage:'--, dead, 1062 days	228.8
TCGA-32-4213-01A	47 years, female, white, stage:'--, alive, 604 days	228.5
TCGA-76-4927-01A	58 years, male, white, stage:'--, dead, 535 days	228.0
TCGA-02-2486-01A	64 years, male, white, stage:'--, dead, 618 days	226.7
TCGA-06-0125-01A	63 years, female, white, stage:'--, dead, 1448 days	225.9
TCGA-06-0645-01A	55 years, female, white, stage:'--, dead, 175 days	225.0
TCGA-32-5222-01A	66 years, male, white, stage:'--, dead, 585 days	224.6
TCGA-06-0644-01A	71 years, male, black or african american, stage:'--, dead, 384 days	222.7
TCGA-76-4929-01A	76 years, female, white, stage:'--, dead, 111 days	222.4
TCGA-06-2558-01A	75 years, female, white, stage:'--, dead, 380 days	221.7
TCGA-76-4932-01A	50 years, female, white, stage:'--, dead, 1458 days	221.5
TCGA-06-0158-01A	73 years, male, white, stage:'--, dead, 329 days	219.6
TCGA-06-0747-01A	53 years, male, white, stage:'--, dead, 82 days	217.8
TCGA-27-1832-01A	59 years, female, white, stage:'--, dead, 300 days	216.9
TCGA-19-5960-01A	56 years, male, white, stage:'--, dead, 455 days	215.1
TCGA-19-4065-01A	36 years, male, white, stage:'--, alive, 214 days	214.0
TCGA-06-5411-01A	51 years, male, white, stage:'--, dead, 254 days	213.3
TCGA-06-0743-01A	69 years, male, white, stage:'--, dead, 803 days	212.4
TCGA-32-2616-01A	48 years, female, white, stage:'--, dead, 224 days	212.4
TCGA-26-5133-01A	59 years, male, white, stage:'--, alive, 452 days	211.1
TCGA-19-2629-01A	60 years, male, white, stage:'--, dead, 737 days	210.4
TCGA-26-5134-01A	74 years, male, white, stage:'--, alive, 167 days	209.2
TCGA-06-0219-01A	67 years, male, white, stage:'--, dead, 22 days	208.2
TCGA-27-2521-01A	34 years, male, white, stage:'--, dead, 510 days	207.5
TCGA-06-5412-01A	78 years, female, white, stage:'--, dead, 138 days	207.1
TCGA-27-1835-01A	53 years, female, white, stage:'--, dead, 648 days	206.2
TCGA-28-1753-01A	53 years, male, white, stage:'--, alive, 37 days	206.1
TCGA-19-2619-01A	55 years, female, black or african american, stage:'--, alive, 294 days	205.5
TCGA-06-2557-01A	76 years, male, black or african american, stage:'--, dead, 33 days	205.1
TCGA-28-5207-01A	71 years, male, white, stage:'--, dead, 343 days	204.7
TCGA-27-1837-01A	36 years, male, white, stage:'--, dead, 427 days	204.1
TCGA-27-2524-01A	56 years, male, white, stage:'--, dead, 231 days	203.8
TCGA-06-0882-01A	30 years, male, white, stage:'--, dead, 632 days	202.8
TCGA-19-2624-01A	51 years, male, white, stage:'--, dead, 5 days	201.8
TCGA-26-5132-01A	74 years, male, white, stage:'--, alive, 286 days	201.1
TCGA-06-2563-01A	72 years, female, white, stage:'--, alive, 932 days	200.7
TCGA-06-0138-01A	43 years, male, white, stage:'--, dead, 737 days	200.2
TCGA-32-2615-01A	62 years, male, white, stage:'--, dead, 485 days	198.3
TCGA-41-2571-01A	89 years, male, white, stage:'--, dead, 26 days	198.2
TCGA-41-2572-01A	67 years, male, white, stage:'--, dead, 406 days	195.6
TCGA-06-2567-01A	65 years, male, white, stage:'--, dead, 133 days	195.4
TCGA-12-0618-01A	49 years, male, white, stage:'--, dead, 395 days	193.3
TCGA-06-0750-01A	43 years, male, white, stage:'--, dead, 28 days	191.3
TCGA-19-1390-01A	63 years, female, white, stage:'--, dead, 772 days	190.9
TCGA-06-5856-01A	58 years, male, white, stage:'--, dead, 114 days	189.4
TCGA-06-5410-01A	72 years, female, white, stage:'--, dead, 108 days	189.3
TCGA-14-1823-01A	58 years, female, white, stage:'--, dead, 543 days	189.0
TCGA-32-1980-01A	72 years, male, white, stage:'--, dead, 36 days	188.9
TCGA-28-2513-01A	69 years, female, white, stage:'--, alive, 222 days	188.2
TCGA-41-4097-01A	63 years, female, white, stage:'--, dead, 6 days	187.1
TCGA-26-1442-01A	43 years, male, white, stage:'--, alive, 953 days	186.4
TCGA-06-0646-01A	60 years, male, white, stage:'--, dead, 175 days	186.2
TCGA-32-1982-01A	76 years, female, white, stage:'--, dead, 142 days	182.5
TCGA-06-0238-01A	46 years, male, white, stage:'--, dead, 405 days	180.4
TCGA-28-2509-01A	77 years, female, white, stage:'--, alive, 145 days	179.1
TCGA-06-0132-01A	49 years, male, white, stage:'--, dead, 771 days	177.8
TCGA-26-5135-01A	72 years, female, white, stage:'--, dead, 270 days	175.1
TCGA-19-2625-01A	76 years, female, white, stage:'--, dead, 124 days	170.3
TCGA-41-3915-01A	48 years, male, white, stage:'--, dead, 360 days	170.1
TCGA-06-0139-01A	40 years, male, white, stage:'--, dead, 362 days	170.1
TCGA-19-2620-01A	70 years, male, white, stage:'--, dead, 148 days	164.8
TCGA-12-3650-01A	46 years, male, white, stage:'--, dead, 333 days	164.6
TCGA-32-2632-01A	80 years, male, white, stage:'--, dead, 269 days	163.8
TCGA-06-0190-01A	62 years, male, white, stage:'--, dead, 317 days	163.7
TCGA-27-1830-01A	57 years, male, white, stage:'--, dead, 154 days	161.7
TCGA-06-1804-01A	81 years, female, white, stage:'--, dead, 414 days	160.3
TCGA-12-0616-01A	36 years, female, white, stage:'--, dead, 448 days	159.6
TCGA-06-0686-01A	53 years, male, white, stage:'--, dead, 432 days	158.6
TCGA-16-0846-01A	85 years, male, white, stage:'--, dead, 119 days	152.6
TCGA-02-0055-01A	62 years, female, white, stage:'--, dead, 76 days	152.2
TCGA-06-0141-01A	62 years, male, white, stage:'--, dead, 313 days	149.8
TCGA-06-0749-01A	50 years, male, black or african american, stage:'--, dead, 82 days	148.6
TCGA-06-2569-01A	24 years, female, black or african american, stage:'--, alive, 13 days	146.8
TCGA-27-1831-01A	66 years, male, white, stage:'--, dead, 505 days	145.4
TCGA-28-5218-01A	63 years, male, white, stage:'--, dead, 157 days	143.5
TCGA-12-0619-01A	60 years, male, white, stage:'--, dead, 1062 days	142.4
TCGA-14-0817-01A	69 years, female, white, stage:'--, dead, 164 days	138.0
TCGA-06-0744-01A	66 years, male, white, stage:'--, dead, 1426 days	136.4
TCGA-06-0178-01A	38 years, male, white, stage:'--, dead, 2681 days	133.7
TCGA-14-0871-01A	74 years, female, white, stage:'--, dead, 880 days	132.6
TCGA-06-0184-01A	63 years, male, white, stage:'--, dead, 2126 days	125.3
TCGA-06-0130-01A	54 years, male, white, stage:'--, dead, 394 days	109.1
Show allShow less

GLIOBLASTOMA MULTIFORME (VALIDATION) - Interactive survival scatter plotⁱ

& Survival analysisⁱ

SPCS2 is not prognostic in Glioblastoma Multiforme (validation)

Stage:

Survival analysis

Current cut offⁱ :

Best expression cut offⁱ : 89.08

Median expressionⁱ : N/A

Median follow up timeⁱ : N/A

P scoreⁱ N/A

3-year survival highⁱ N/A

3-year survival lowⁱ N/A

TCGA RNA samplesⁱ

Average pTPM

84.0

Number of samples

Samples

Sample	Description	pTPM
AK002	N, NA, stage:NA, dead, 570 days	185.8
AK117	N, NA, stage:NA, dead, 210 days	167.0
AK099	N, NA, stage:NA, dead, 420 days	166.6
AK006	N, NA, stage:NA, dead, 360 days	164.2
AK123	N, NA, stage:NA, dead, 180 days	142.9
AK226	N, NA, stage:NA, dead, 360 days	140.7
AK205	N, NA, stage:NA, dead, 120 days	129.5
AK043	N, NA, stage:NA, alive, 660 days	121.6
AK133	N, NA, stage:NA, dead, 360 days	119.8
AK079	N, NA, stage:NA, dead, 210 days	117.6
AK089	N, NA, stage:NA, dead, 330 days	108.8
AK035	N, NA, stage:NA, dead, 210 days	107.4
AK081	N, NA, stage:NA, dead, 180 days	105.0
AK088	N, NA, stage:NA, dead, 360 days	101.0
AK218	N, NA, stage:NA, dead, 180 days	96.8
AK005	N, NA, stage:NA, dead, 240 days	94.5
AK134	N, NA, stage:NA, dead, 360 days	91.6
AK091	N, NA, stage:NA, dead, 210 days	89.2
AK041	N, NA, stage:NA, alive, 810 days	89.0
AK227	N, NA, stage:NA, alive, 300 days	89.0
AK158	N, NA, stage:NA, dead, 360 days	88.0
AK074	N, NA, stage:NA, alive, 300 days	84.7
AK100	N, NA, stage:NA, alive, 960 days	81.9
AK236	N, NA, stage:NA, dead, 360 days	81.8
AK085	N, NA, stage:NA, alive, 660 days	80.8
AK188	N, NA, stage:NA, alive, 420 days	80.4
AK173	N, NA, stage:NA, dead, 180 days	79.1
AK167	N, NA, stage:NA, dead, 180 days	77.2
AK030	N, NA, stage:NA, dead, 120 days	76.8
AK102	N, NA, stage:NA, alive, 1740 days	73.9
AK051	N, NA, stage:NA, dead, 360 days	73.4
AK071	N, NA, stage:NA, dead, 540 days	73.3
AK153	N, NA, stage:NA, dead, 240 days	72.4
AK156	N, NA, stage:NA, dead, 330 days	71.7
AK216	N, NA, stage:NA, dead, 360 days	71.3
AK149	N, NA, stage:NA, dead, 420 days	70.9
AK139	N, NA, stage:NA, dead, 270 days	70.4
AK049	N, NA, stage:NA, dead, 180 days	67.2
AK103	N, NA, stage:NA, alive, 1320 days	67.0
AK068	N, NA, stage:NA, alive, 360 days	66.4
AK076	N, NA, stage:NA, alive, 660 days	62.3
AK015	N, NA, stage:NA, alive, 720 days	62.0
AK178	N, NA, stage:NA, dead, 240 days	61.7
AK098	N, NA, stage:NA, dead, 660 days	60.4
AK195	N, NA, stage:NA, dead, 390 days	60.1
AK066	N, NA, stage:NA, alive, 960 days	58.2
AK124	N, NA, stage:NA, alive, 1920 days	56.8
AK055	N, NA, stage:NA, dead, 240 days	56.1
AK072	N, NA, stage:NA, dead, 150 days	53.1
AK003	N, NA, stage:NA, dead, 600 days	52.0
AK199	N, NA, stage:NA, alive, 1860 days	51.6
AK142	N, NA, stage:NA, alive, 90 days	51.4
AK231	N, NA, stage:NA, dead, 240 days	49.6
AK183	N, NA, stage:NA, alive, 360 days	45.7
AK053	N, NA, stage:NA, dead, 300 days	43.2
AK185	N, NA, stage:NA, alive, 330 days	40.1
AK213	N, NA, stage:NA, alive, 2010 days	38.4
AK165	N, NA, stage:NA, alive, 360 days	35.8
Show allShow less

GLIOBLASTOMA MULTIFORME - Protein relative expression (CPTAC)

Number of samples

110

Samples

Sample ID	Sample type	nRPX
CPT0207090003	Tumor	0.7
CPT0206560003	Tumor	0.6
CPT0167750004	Tumor	0.6
CPT0168080003	Tumor	0.5
CPT0093590003	Tumor	0.5
CPT0218330004	Tumor	0.5
CPT0161730003	Tumor	0.5
CPT0217060003	Tumor	0.5
CPT0224390004	Tumor	0.4
CPT0167530003	Tumor	0.4
CPT0224600003	Tumor	0.3
CPT0217100003	Tumor	0.3
CPT0186100003	Tumor	0.3
CPT0217710008	Tumor	0.3
CPT0125510003	Tumor	0.3
CPT0093510003	Tumor	0.3
CPT0206670004	Tumor	0.3
CPT0206780003	Tumor	0.3
CPT0205670004	Tumor	0.3
CPT0002410011	Tumor	0.3
CPT0171580008	Tumor	0.3
CPT0225760003	Tumor	0.3
CPT0225730003	Tumor	0.3
CPT0167860004	Tumor	0.2
CPT0217430008	Tumor	0.2
CPT0218890004	Tumor	0.2
CPT0208980003	Tumor	0.2
CPT0087950003	Tumor	0.2
CPT0078580003	Tumor	0.2
CPT0182500003	Tumor	0.2
CPT0093450003	Tumor	0.2
CPT0218830004	Tumor	0.2
CPT0207030003	Tumor	0.2
CPT0167970003	Tumor	0.2
CPT0093360003	Tumor	0.2
CPT0205780003	Tumor	0.2
CPT0182580003	Tumor	0.2
CPT0189570004	Tumor	0.2
CPT0168830003	Tumor	0.2
CPT0167640003	Tumor	0.2
CPT0201710003	Tumor	0.2
CPT0168480003	Tumor	0.2
CPT0175060003	Tumor	0.1
CPT0217880003	Tumor	0.1
CPT0205450004	Tumor	0.1
CPT0127480003	Tumor	0.1
CPT0104330003	Tumor	0.1
CPT0168720003	Tumor	0.1
CPT0071100003	Tumor	0.1
CPT0218690004	Tumor	0.1
CPT0199770003	Tumor	0.1
CPT0216920008	Tumor	0.1
CPT0168590003	Tumor	0.1
CPT0168380003	Tumor	0.1
CPT0087570003	Tumor	0.1
CPT0189850004	Tumor	0.1
CPT0219080004	Tumor	0.1
CPT0190360004	Tumor	0.0
CPT0206000004	Tumor	0.0
CPT0123530003	Tumor	0.0
CPT0162140003	Tumor	0.0
CPT0228220003	Tumor	0.0
CPT0125570003	Tumor	0.0
CPT0206110003	Tumor	0.0
CPT0221180003	Tumor	0.0
CPT0064890003	Tumor	0.0
CPT0217190003	Tumor	0.0
CPT0089150003	Tumor	0.0
CPT0206230003	Tumor	0.0
CPT0217000004	Tumor	0.0
CPT0189750004	Tumor	0.0
CPT0104220003	Tumor	0.0
CPT0224330003	Tumor	-0.1
CPT0205890003	Tumor	-0.1
CPT0206880003	Tumor	-0.1
CPT0189460003	Tumor	-0.1
CPT0092440003	Tumor	-0.1
CPT0189650004	Tumor	-0.1
CPT0205570003	Tumor	-0.1
CPT0064650003	Tumor	-0.1
CPT0162100003	Tumor	-0.1
CPT0079790003	Tumor	-0.1
CPT0209440003	Tumor	-0.1
CPT0190240004	Tumor	-0.1
CPT0087680003	Tumor	-0.1
CPT0125220003	Tumor	-0.1
CPT0224540004	Tumor	-0.1
CPT0127420003	Tumor	-0.1
CPT0196850003	Tumor	-0.2
CPT0218670003	Tumor	-0.2
CPT0206450003	Tumor	-0.2
CPT0206330003	Tumor	-0.3
CPT0087730003	Tumor	-0.3
CPT0182550003	Tumor	-0.3
CPT0189250003	Tumor	-0.3
CPT0218960004	Tumor	-0.3
CPT0168270003	Tumor	-0.3
CPT0204340003	Normal	-0.4
CPT0218770003	Tumor	-0.4
CPT0093550003	Tumor	-0.4
CPT0204370003	Normal	-0.4
CPT0162020003	Tumor	-0.4
CPT0204410003	Normal	-0.4
CPT0204380003	Normal	-0.4
CPT0204330003	Normal	-0.4
CPT0204420003	Normal	-0.5
CPT0204400003	Normal	-0.6
CPT0204390003	Normal	-0.6
CPT0204360003	Normal	-0.6
CPT0204350003	Normal	-0.9
Show allShow less

GLIOMA - Protein expressionⁱ A mouse-over function shows sample information and annotation data. Click on an image to view it in a full screen mode. Samples can be filtered based on level of antibody staining by selecting one or several of the following categories: high, medium, low and not detected. The assay and annotation is described here. Note that samples used for immunohistochemistry by the Human Protein Atlas do not correspond to samples in the TCGA dataset.

Antibody stainingⁱ Antibody staining in the annotated cell types in the current human tissue is reported as not detected, low, medium, or high, based on conventional immunohistochemistry profiling in selected tissues. This score is based on the combination of the staining intensity and fraction of stained cells. Each image is clickable and will lead to virtual microscopy that enables deeper exploration of all samples and also displays staining intensity scores, fraction scores and subcellular localization as well as patient and tissue information for each sample.	Antibody HPA013386
Staining
High
Medium
Low
Not detected
Intensity
Strong
Moderate
Weak
Negative
Quantity
>75%
75%-25%
<25%
None
Location
Nuclear
Cytoplasmic/membranous
Cytoplasmic/membranous,nuclear
None
Glioma, malignant, Low grade
Glioma, malignant, High grade